Skip to main content
Premium Trial:

Request an Annual Quote

Gates Foundation Awards Somalogic Additional Funding for Tuberculosis Biomarker Work

Premium

NEW YORK (GenomeWeb News) – Somalogic said this week that it has received additional funding from the Bill & Melinda Gates Foundation for the development and validation of tuberculosis biomarker assays based on its Somamer technology.

The funding expands upon an initial grant awarded in 2012 by the foundation to Somalogic for work on assays that detect TB proteins and monitor infection-related changes to host proteins.

With the new funding, Somalogic researchers will evaluate the feasibility of a rapid TB diagnostic based on these assays, as well as investigate the diagnostic's performance in sample types such as serum, plasma, and urine.

The Gates Foundation's support "will help us accelerate the realization of our shared goal of defining a low-cost, simple to use tool that can quickly and accurately diagnose TB in developing countries," Urs Ochsner, head of Somalogic's infectious diseases research group, said in a statement.

Financial details of the supplemental grant were not disclosed.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.